Thrombophilia in ischemic stroke.
作者信息
Potti A, Rabadi K M, Willardsen D D
机构信息
Department of Internal Medicine, MeritCare Medical Center, University of North Dakota School of Medicine and Health Sciences, Fargo, North Dakota, USA.
出版信息
West J Med. 1998 Dec;169(6):385-6.
Abstract
摘要
相似文献
1
Thrombophilia in ischemic stroke.缺血性卒中中的血栓形成倾向
West J Med. 1998 Dec;169(6):385-6.
2
[Management of acute stroke].[急性中风的管理]
Duodecim. 1989;105(7):691-9.
3
Screening for coagulation disorders in patients with ischemic stroke.筛查缺血性脑卒中患者的凝血障碍。
Expert Rev Neurother. 2010 Aug;10(8):1321-9. doi: 10.1586/ern.10.104.
4
[Cerebral ischemia in young adults].[年轻成年人的脑缺血]
Fortschr Neurol Psychiatr. 1991 Aug;59(8):322-7. doi: 10.1055/s-2007-1000706.
5
The risk of embolic stroke. Another piece of the puzzle.栓塞性中风的风险。谜题的另一部分。
N Engl J Med. 1994 Dec 1;331(22):1517-9. doi: 10.1056/NEJM199412013312211.
6
[Pathogenetic aspects of ischemic strokes].[缺血性中风的发病机制方面]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1988;88(1):9-12.
7
[Role of mitral valve prolapse in the pathogenesis of cerebral infarction].二尖瓣脱垂在脑梗死发病机制中的作用
Zh Nevropatol Psikhiatr Im S S Korsakova. 1985;85(9):1292-6.
8
Ischemic stroke in patients under age 45.
Neurol Clin. 1992 Feb;10(1):113-24.
9
[Lupus anticoagulant and cerebrovascular stroke].[狼疮抗凝物与脑血管卒中]
Med Clin (Barc). 1988 Feb 20;90(7):280-2.
10
Cerebral and retinal vascular complications of inflammatory bowel disease.
Ann Neurol. 1979 Apr;5(4):331-7. doi: 10.1002/ana.410050405.
本文引用的文献
1
Risk factors for venous thrombosis: prevalence, risk, and interaction.静脉血栓形成的危险因素：患病率、风险及相互作用。
Semin Hematol. 1997 Jul;34(3):171-87.
2
Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis.真性红细胞增多症和原发性血小板增多症血栓形成患者抗凝血酶III、蛋白C和蛋白S水平降低及活化蛋白C抵抗
Am J Hematol. 1996 May;52(1):14-20. doi: 10.1002/(SICI)1096-8652(199605)52:1<14::AID-AJH3>3.0.CO;2-9.
3
High plasma levels of plasminogen activator inhibitor 1 (PAI-1) in polycythemia vera and essential thrombocythemia are associated with thrombosis.真性红细胞增多症和原发性血小板增多症患者血浆中纤溶酶原激活物抑制剂1（PAI-1）水平升高与血栓形成有关。
Thromb Res. 1994 Sep 1;75(5):513-20. doi: 10.1016/0049-3848(94)90226-7.
4
Risk factors and outcomes for ischemic stroke.缺血性中风的风险因素及预后
Neurology. 1995 Feb;45(2 Suppl 1):S10-4.
5
Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis.羟基脲用于原发性血小板增多症且有高血栓形成风险的患者。
N Engl J Med. 1995 Apr 27;332(17):1132-6. doi: 10.1056/NEJM199504273321704.
6
Low proteins C and S and activation of fibrinolysis in treated essential thrombocythemia.
Am J Hematol. 1995 Aug;49(4):277-81. doi: 10.1002/ajh.2830490404.
7
Ischemic stroke as first manifestation of essential thrombocythemia. Report of six cases.
Stroke. 1995 Aug;26(8):1463-6. doi: 10.1161/01.str.26.8.1463.
8
Hypercoagulability in acute stroke: prognostic significance.急性卒中的高凝状态：预后意义
Neurology. 1987 Oct;37(10):1667-71. doi: 10.1212/wnl.37.10.1667.
9
Hematologic disorders and ischemic stroke. A selective review.血液系统疾病与缺血性卒中。选择性综述。
Stroke. 1990 Aug;21(8):1111-21. doi: 10.1161/01.str.21.8.1111.
Zotero 插件